Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache
NCT05365880 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2024-11-13
Summary
Determine the effects of sphenopalatine ganglion (SPG) block in post-stroke headache.
Conditions
Interventions
- DRUG
-
Liquid Lidocaine
The investigational treatment is 2 mL of aqueous 2% lidocaine.
- DRUG
-
The active placebo comparator will be provided to participant.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Adam H de Havenon, MD · University of Utah
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-23
- Primary Completion
- 2025-03-22
- Completion
- 2025-06-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Sphenopalatine Ganglion Block and Cold Induced Headaches
NCT06310200 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage
NCT07054801 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department
NCT02517931 ·Status: WITHDRAWN ·Phase: NA
-
Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)
NCT02365909 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Randomized Controlled Trial
NCT07307508 ·Status: RECRUITING ·Phase: NA
-
Superior Cervical Sympathetic Block Versus Stellate Ganglion Block in Post-traumatic Subarachnoid Hemorrhage
NCT06134583 ·Status: COMPLETED ·Phase: NA
-
SGB in Management of Patients With PDPH Using TCD
NCT04401878 ·Status: COMPLETED ·Phase: NA
-
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
NCT04580238 ·Status: WITHDRAWN ·Phase: PHASE1
-
BLOCK-SAH - PPF-Block for Post-SAH Headache
NCT06008795 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin
NCT02999048 ·Status: COMPLETED ·Phase: PHASE4
-
Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage
NCT02330094 ·Status: COMPLETED ·Phase: PHASE4
-
Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter
NCT02872636 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Scalp Block on Hemodynamic Stability and Opioid Consumption During Craniotomy
NCT02880566 ·Status: UNKNOWN ·Phase: NA
-
Sphenopalatine Ganglion Block and Pain Management in Neurosurgery
NCT05136625 ·Status: UNKNOWN ·Phase: NA
-
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
NCT07294118 ·Status: RECRUITING ·Phase: PHASE2
-
The Sphenopalatine Ganglion Block for Post-dural Puncture Headache
NCT03385772 ·Status: UNKNOWN ·Phase: NA
-
Cervical Sympathetic Block in Patients With Cerebral Vasospasm
NCT05230134 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage
NCT05925478 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
NCT06582810 ·Status: RECRUITING
-
Sphenopalatine Blockade Versus Clinical Treatment
NCT04148846 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Vasospasm in SAH Through CSF Treatment
NCT04490161 ·Status: RECRUITING ·Phase: NA
-
Identification of Novel Molecular Markers for Vasospasm
NCT02389634 ·Status: COMPLETED
-
Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
NCT00930072 ·Status: TERMINATED ·Phase: PHASE2
-
FILtration of Subarachnoid Hemorrhage Via SpinaL CAtheteR Extension
NCT03607825 ·Status: COMPLETED ·Phase: NA
-
Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery
NCT05062148 ·Status: WITHDRAWN ·Phase: NA